| Trial ID: | L0530 |
| Source ID: | IRCT2014110511763N18
|
| Associated Drug: |
Curcumin
|
| Title: |
Effect of curcumin on liver function enzymes in patients with NAFLD
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
nonalcholic fatty liver. <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
|
| Interventions: |
Intervention 1: Intervention: curcumin, Capsules, 500 mg orally, once daily for 2 months. Intervention 2: Control: placebo (bass calcium phosphate) Capsules 500 mg orally, once daily for 2 months.;Placebo;Placebo;Intervention: curcumin, Capsules, 500 mg o
|
| Outcome Measures: |
ALT. Timepoint: Before and after study. Method of measurement: Enzymatic photometric.;AST. Timepoint: Before and after study. Method of measurement: Enzymatic photometric.TG. Timepoint: Before and after study. Method of measurement: Enzymatic.;Tch. Timepoint: Before and after study. Method of measurement: Enzymatic.;HDL. Timepoint: Before and after study. Method of measurement: Enzymatic.;LDL. Timepoint: Before and after study. Method of measurement: Fried Wald Equation equation.;Hs-CRP. Timepoint: Before and after study. Method of measurement: Aymynvasy sensitive enzymatic.;F.B.S. Timepoint: Before and after study. Method of measurement: Enzymatic.;HBA1C. Timepoint: Before and after study. Method of measurement: Enzymatic.
|
| Sponsor/Collaborators: |
Isfahan University of Medical Sciences
|
| Gender: |
All
|
| Age: |
76 yearsno limit
|
| Phases: |
Not applicable
|
| Enrollment: |
80
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
18/01/2015
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/11928
|
